| Personalized immunomonitoring uncovers molecular networks that stratify lupus patients R Banchereau, S Hong, B Cantarel, N Baldwin, J Baisch, M Edens, ... Cell 165 (3), 551-565, 2016 | 708 | 2016 |
| Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency B Boisson, E Laplantine, C Prando, S Giliani, E Israelsson, Z Xu, ... Nature immunology 13 (12), 1178-1186, 2012 | 467 | 2012 |
| Systems Scale Interactive Exploration Reveals Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines G Obermoser, S Presnell, K Domico, H Xu, Y Wang, E Anguiano, ... Immunity 38 (4), 831-844, 2013 | 303 | 2013 |
| RNA recognition by human TLR8 can lead to autoimmune inflammation C Guiducci, M Gong, AM Cepika, Z Xu, C Tripodo, L Bennett, C Crain, ... Journal of Experimental Medicine 210 (13), 2903-2919, 2013 | 218 | 2013 |
| IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer TC Wu, K Xu, J Martinek, RR Young, R Banchereau, J George, J Turner, ... Cancer research 78 (18), 5243-5258, 2018 | 161 | 2018 |
| Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency AM Cepika, Y Sato, JMH Liu, MJ Uyeda, R Bacchetta, MG Roncarolo The Journal of Allergy and Clinical Immunology 142 (6), 1679–1695, 2018 | 137 | 2018 |
| Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics R Banchereau, AM Cepika, J Banchereau, V Pascual Annual Review of Immunology 35, 2017 | 84 | 2017 |
| Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines R Banchereau, N Baldwin, AM Cepika, S Athale, Y Xue, CI Yu, P Metang, ... Nature communications 5 (1), 5283, 2014 | 75 | 2014 |
| Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy S Hong, R Banchereau, BSL Maslow, MM Guerra, J Cardenas, J Baisch, ... Journal of Experimental Medicine 216 (5), 1154-1169, 2019 | 60 | 2019 |
| A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis AM Cepika, R Banchereau, E Segura, M Ohouo, B Cantarel, K Goller, ... Journal of Experimental Medicine 214 (11), 3449-3466, 2017 | 56 | 2017 |
| Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients PP Chen, AM Cepika, R Agarwal-Hashmi, G Saini, MJ Uyeda, DM Louis, ... Science Translational Medicine 13 (617), eabf5264, 2021 | 43 | 2021 |
| Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up AM Cepika, I Marinić, J Morović-Vergles, D Soldo-Jureša, A Gagro Lupus 16 (5), 374-377, 2007 | 41 | 2007 |
| Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment AM Cepika, DS Jureša, JM Vergles, B Malenica, M Šantak, S Kapitanović, ... Cellular Immunology, 2012 | 36 | 2012 |
| Type I cytokine profiles of human naive and memory B lymphocytes: a potential for memory cells to impact polarization A Gagro, D Servis, AM Cepika, KM Toellner, G Grafton, DR Taylor, ... Immunology 118 (1), 66-77, 2006 | 34 | 2006 |
| Expression of chemokine receptor CX3CR1 in infants with respiratory syncytial virus bronchiolitis AM Cepika, A Gagro, A Bace, D Tjesic‐Drinkovic, J Kelecic, ... Pediatric Allergy and Immunology 19 (2), 148-156, 2008 | 24 | 2008 |
| Systems approaches to human autoimmune diseases R Banchereau, AM Cepika, V Pascual Current opinion in immunology 25 (5), 598-605, 2013 | 20 | 2013 |
| Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus AM Cepika, K Bendelja, JM Vergles, B Malenica, S Kapitanovic, A Gagro Scandinavian journal of immunology 72 (5), 434-443, 2010 | 18 | 2010 |
| BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation MJ Uyeda, RA Freeborn, B Cieniewicz, R Romano, P Chen, JMH Liu, ... Frontiers in immunology 12, 683680, 2021 | 14 | 2021 |
| Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells B Cieniewicz, MJ Uyeda, PP Chen, EC Sayitoglu, JMH Liu, G Andolfi, ... Haematologica, https://doi.org/10.3324/haematol.2020.26, 2020 | 14 | 2020 |
| Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy JMH Liu, P Chen, MJ Uyeda, B Cieniewicz, EC Sayitoglu, BC Thomas, ... Cytotherapy 23 (11), 1017-1028, 2021 | 6 | 2021 |
